Wiercinska-Drapalo A - Search Results

1

Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.

Reekie J, Kosa C, Engsig F, Monforte Ad, Wiercinska-Drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, Lundgren JD, Mocroft A; EuroSIDA Study Group. Reekie J, et al. Cancer. 2010 Nov 15;116(22):5306-15. doi: 10.1002/cncr.25311. Cancer. 2010. PMID: 20661911 Free article.

2

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group. Cozzi-Lepri A, et al. AIDS. 2008 Oct 18;22(16):2187-98. doi: 10.1097/QAD.0b013e328310e04f. AIDS. 2008. PMID: 18832882

3

Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.

Lapinski TW, Jaroszewicz J, Wiercinska-Drapalo A. Lapinski TW, et al. Viral Immunol. 2006 Summer;19(3):570-5. doi: 10.1089/vim.2006.19.570. Viral Immunol. 2006. PMID: 16987075

4

[Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland].

Stańczak GP, Stańczak JJ, Firlag-Burkacka E, Wiercińska-Drapało A, Leszczyszyn-Pynkad M, Jabłonowska E, Małolepsza E, Horban A. Stańczak GP, et al. Przegl Epidemiol. 2007;61(1):29-34. Przegl Epidemiol. 2007. PMID: 17702436 Polish.

5

Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008.

Stańczak GP, Stańczak JJ, Marczyńska M, Firlag-Burkacka E, Wiercińska-Drapało A, Leszczyszyn-Pynka M, Jabłonowska E, Małolepsza E, Dyda T, Zabek P, Horban A. Stańczak GP, et al. J Med Virol. 2010 Jul;82(7):1291-4. doi: 10.1002/jmv.21782. J Med Virol. 2010. PMID: 20513098

6

Comparative analysis of the new chronic kidney disease epidemiology collaboration and the modification of diet in renal disease equations for estimation of glomerular filtration rate in HIV type 1-infected subjects.

Dabrowska MM, Mikula T, Stanczak W, Malyszko J, Wiercinska-Drapalo A. Dabrowska MM, et al. AIDS Res Hum Retroviruses. 2011 Aug;27(8):809-13. doi: 10.1089/AID.2010.0233. Epub 2011 Mar 2. AIDS Res Hum Retroviruses. 2011. PMID: 21284524

7

Risk Factors of Hypovitaminosis D in HIV-Infected Patients on Suppressive Antiretroviral Therapy.

Mikuła T, Sapuła M, Suchacz MM, Kozłowska J, Krankowska D, Stańczak W, Wiercińska-Drapało A. Mikuła T, et al. AIDS Res Hum Retroviruses. 2020 Aug;36(8):676-680. doi: 10.1089/AID.2019.0020. Epub 2020 Jun 8. AIDS Res Hum Retroviruses. 2020. PMID: 32408752

8

Impact of Combined Antiretroviral Therapy on Metabolic Syndrome Components in Adult People Living with HIV: A Literature Review.

Sapuła M, Suchacz M, Załęski A, Wiercińska-Drapało A. Sapuła M, et al. Viruses. 2022 Jan 11;14(1):122. doi: 10.3390/v14010122. Viruses. 2022. PMID: 35062326 Free PMC article. Review.

9

[The central nervous system and HIV infection].

Wiercińska-Drapało A, Tarasów E, Jaroszewicz J. Wiercińska-Drapało A, et al. Neurol Neurochir Pol. 2003;37 Suppl 2:15-9. Neurol Neurochir Pol. 2003. PMID: 14560704 Review. Polish.

10

Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.

Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D. Wiercinska-Drapalo A, et al. World J Gastroenterol. 2003 Dec;9(12):2843-5. doi: 10.3748/wjg.v9.i12.2843. World J Gastroenterol. 2003. PMID: 14669348 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters